Abstract
The rising incidence of cardiovascular and metabolic diseases in industrialized countries has led the pharmaceutical industry to make them key areas of drug development. These diseases imply a clustering of metabolic factors where lipid metabolites play a relevant role. Measurement of pharmacodynamic endpoints of drugs on lipid metabolism pathways and downstream biological processes appear crucial for a rational drug discovery/development. Fortunately, recent mass spectrometers with an enhanced sensitivity and resolution in combination with multivariate statistical analysis provide the practical possibility to analyze and measure wide portions of the lipidome. The final goal is to identify lipid signatures which fit with specific pharmacologic responses to therapeutic intervention. Focusing on applications of lipidomics for drug development this review outlines the methodological steps, from analytical measurements to data processing and to graphical representation, for an efficient implementation of informative lipid signatures.
Keywords: Lipidomics, metabolic syndrome, pharmacodynamics, diabesity, mass spectrometry, multivariate analysis, cardiovascular and metabolic diseases, mass spectrometers, statistical analysis, therapeutic intervention
Current Pharmaceutical Biotechnology
Title:Application of Lipidomics to Assess Lipogenesis in Drug Development and Pre-Clinical Trials
Volume: 13 Issue: 5
Author(s): Antonin Lamaziere, Claude Wolf, Peter J. Quinn
Affiliation:
Keywords: Lipidomics, metabolic syndrome, pharmacodynamics, diabesity, mass spectrometry, multivariate analysis, cardiovascular and metabolic diseases, mass spectrometers, statistical analysis, therapeutic intervention
Abstract:
The rising incidence of cardiovascular and metabolic diseases in industrialized countries has led the pharmaceutical industry to make them key areas of drug development. These diseases imply a clustering of metabolic factors where lipid metabolites play a relevant role. Measurement of pharmacodynamic endpoints of drugs on lipid metabolism pathways and downstream biological processes appear crucial for a rational drug discovery/development. Fortunately, recent mass spectrometers with an enhanced sensitivity and resolution in combination with multivariate statistical analysis provide the practical possibility to analyze and measure wide portions of the lipidome. The final goal is to identify lipid signatures which fit with specific pharmacologic responses to therapeutic intervention. Focusing on applications of lipidomics for drug development this review outlines the methodological steps, from analytical measurements to data processing and to graphical representation, for an efficient implementation of informative lipid signatures.
Export Options
About this article
Cite this article as:
Antonin Lamaziere, Claude Wolf, Peter J. Quinn , Application of Lipidomics to Assess Lipogenesis in Drug Development and Pre-Clinical Trials, Current Pharmaceutical Biotechnology 2012; 13 (5) . https://dx.doi.org/10.2174/138920112799857521
DOI https://dx.doi.org/10.2174/138920112799857521 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Drug Repurposing in Chemical Genomics: Can We Learn from the Past to Improve the Future?
Current Topics in Medicinal Chemistry Statins, Risk of Death and Ischemic Stroke in Patients with Dementia: A Registry-Based Observational Cohort Study
Current Alzheimer Research Usefulness of Home Blood Pressure in the Diagnosis and Control of Hypertension in Primary Care
Current Hypertension Reviews Statins in Diabetes Mellitus
Current Pharmaceutical Design Misoprostol Reverse Hippocampal Neuron Cyclooxygenase-2 Downstream Signaling Imbalance in Aluminum-Overload Rats
Current Alzheimer Research Stem Cells in Stroke Repair: Current Success & Future Prospects
CNS & Neurological Disorders - Drug Targets Extra Virgin Olive Oil and Cardiovascular Diseases: Benefits for Human Health
Endocrine, Metabolic & Immune Disorders - Drug Targets Development and Validation of a UPLC–MS/MS Method for the Simultaneous Determination of Telmisartan and Metformine HCl in Human Plasma
Current Analytical Chemistry Associations between Periodontitis and Systemic Inflammatory Diseases: Response to Treatment
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Activity-dependent Synaptic Plasticity and Metaplasticity in Spinal Motor Networks
Current Pharmaceutical Design Simultaneous Determination of Simvastatin with Caffeine in Bulk Drug, Formulation and their Monitoring in Mice Plasma Through HPLC-PDA Technique
Current Analytical Chemistry Effectors of Fatty Acid Oxidation Reduction: Promising New Anti-Ischaemic Agents
Current Pharmaceutical Design Role of Statins in Diabetes Complications
Current Diabetes Reviews Clinical Consequences and Novel Therapy of Hyperphosphatemia: Lanthanum Carbonate for Dialysis Patients
Recent Patents on Cardiovascular Drug Discovery Role of Protein Phosphatase 2A in Alzheimers Disease
Current Alzheimer Research Melatonin, a Potential Therapeutic Agent for Smooth Muscle-Related Pathological Conditions and Aging
Current Medicinal Chemistry Modeling the Interactions Between α1-Adrenergic Receptors and Their Antagonists
Current Computer-Aided Drug Design Winning a Won Game: Caffeine Panacea for Obesity Syndemic
Current Neuropharmacology Inactivation of Parathyroid Hormone: Perspectives of Drug Discovery to Combating Hyperparathyroidism
Current Molecular Pharmacology New Bidirectional Heavy Device for Launching Bridges Based on Inverted Caterpillar Mechanism
Recent Patents on Mechanical Engineering